Alpenglow Biosciences and Prof. Maria Hordinsky to Unveil 3D Imaging Advances for Alopecia and Skin Diseases at SID 2025

Alpenglow Biosciences is set to sponsor a featured speaker session and networking lunch at the Society for Investigative Dermatology (SID) 2025 Annual Meeting in San Diego. The event will provide attendees with an in-depth look at cutting-edge 3D pathology technologies that are revolutionizing the way we understand and treat skin diseases, particularly alopecia. The session, titled "Advancing Dermatology: 3D Pathology Innovations and Clinical Applications in Alopecia and Other Skin Diseases," is scheduled for Thursday, May 8, 2025, from 12:45 PM to 1:45 PM in Sapphire A/B at the Hilton San Diego Bayfront Hotel. Attendees will enjoy a complimentary lunch while engaging with experts and peers in the field. The clinical presentation will be delivered by Maria Hordinsky, MD, the R.W. Goltz Professor and Vice Chair of Research in the Department of Dermatology at the University of Minnesota. Dr. Hordinsky is globally renowned for her work on hair and scalp disorders, and her research has significantly enhanced our understanding of the neuroimmune system's role in alopecia and other inflammatory skin conditions. Nick Reder, MD, MPH, Founder and CEO of Alpenglow Biosciences, will provide the technical presentation. Dr. Reder will delve into the capabilities of Alpenglow’s 3D imaging platform, which captures full-thickness skin at cellular resolution. This technology allows for non-destructive visualization of the intricate nerve structures, immune architecture, and the neuroimmune interface, offering unprecedented insights into skin diseases. In addition to the main session, Alpenglow Biosciences will showcase its 3D Derm Score™ and 3D spatial imaging technologies through three collaborative posters. These posters highlight recent advancements in the study of alopecia, atopic dermatitis, and Mohs micrographic surgery, demonstrating the versatility and potential of the company's technologies. For those interested in learning more about Alpenglow’s program at SID 2025, the company encourages visitors to check out the full schedule of events, including poster details and booth information, on their website at alpenglowbiosciences.com/sid-2025. Attendees can also schedule one-on-one meetings to discuss the latest developments and potential partnerships. Alpenglow Biosciences is a venture-backed company dedicated to advancing drug development and improving clinical diagnostics through AI-enabled 3D spatial imaging technology. Their innovative platform non-destructively digitizes entire tissues, providing detailed spatial biology insights with enhanced accuracy. By partnering with major pharmaceutical companies, Alpenglow aims to accelerate the development of more effective therapies, reduce costs, and enhance patient outcomes. Currently, five of the top 10 pharmaceutical firms collaborate with Alpenglow to leverage these technologies and gain deeper insights into drug mechanisms, efficacy, toxicology, and patient trial enrollment. For further information about Alpenglow Biosciences and their contributions to the field, visit www.alpenglowbiosciences.com. The company's commitment to transforming dermatological research and care through advanced 3D imaging technologies promises exciting developments in the treatment of alopecia and other skin conditions.